It is estimated that in 2023, more than 3100 people were diagnosed with bladder cancer in Australia.¹ Incidence and mortality of bladder cancer is approximately three- to fourfold higher in males than females.²

In 2011, the US Preventive Services Task Force found that there is inadequate evidence that treatment of bladder cancer detected from screening leads to lowered rates of morbidity and mortality, and similarly a lack of evidence regarding the harms of screening for bladder cancer.³

There are no specific recommendations for Aboriginal and Torres Strait Islander people.